STK17B and metabolic dysfunction-associated steatotic liver disease: In addition, Drak2 has been reported to be involved in the pathogenesis of other metabolic diseases, such as nonalcoholic fatty liver disease, and the mechanism by which Drak2 affects mitochondrial function through alternative splicing has been elucidated.